These data reveal a new mechanism underlying lncRNA OTUD6B-AS1-mediated signaling that promotes As2O3 cytotoxicity against bladder cancer, suggesting a potential new strategy to facilitate the development of As2O3 for use in treatment of bladder cancer. This evidence concerns the gene OTUD6B and urinary bladder cancer.